Concepedia

Jennifer Kimberly Lue

JK

22

Publications

1.2K

Citations

16

H-Index

2011

Active since

Affiliations

Columbia University Irving Medical Center(Current)

Moffitt Cancer Center

Columbia University

Memorial Sloan Kettering Cancer Center

University of Washington

Jennifer Kimberly Lue is an author at Columbia University Irving Medical Center specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

2011–2024

22

Publications

22

Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study

Lorenzo Falchi, Helen Ma, Sandra E. Klein et al. · Blood · 2020 · 174 citations · Full text

Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission

Daniel J. Landsburg, Marissa K. Falkiewicz, Joseph Maly et al. · Journal of Clinical Oncology · 2017 · 173 citations · Full text

, , +15

A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma

Jennifer E. Amengual, Renee Lichtenstein, Jennifer Kimberly Lue et al. · Blood · 2017 · 128 citations · Full text

Oral 5-azacytidine and romidepsin exhibit marked activity in patients with PTCL: a multicenter phase 1 study

Owen A. O’Connor, Lorenzo Falchi, Jennifer Kimberly Lue et al. · Blood · 2019 · 127 citations · Full text

Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1–2 trial

Owen A. O’Connor, Jennifer Kimberly Lue, Ahmed Sawas et al. · The Lancet Oncology · 2017 · 113 citations · Full text

, , +5

Rows per page

1–5 of 22